TNFRSF4 and neoplasm: The effect of the CpG + anti-OX40 treatment was already seen, as in 4 of the group’s 10 mice the tumor size was largely reduced (20–50%), in 1 mouse the tumor was no longer detectable, and in 2 mice the tissue proliferation did not increase further.